The Discounted Cash Flow (DCF) valuation of Biodesix, Inc. (BDSX) is (8.77) USD. With the latest stock price at 0.29 USD, the upside of Biodesix, Inc. based on DCF is -3154.6%.
Based on the latest price of 0.29 USD and our DCF valuation, Biodesix, Inc. (BDSX) is a sell. selling Biodesix, stocks now will result in a potential gain of 3154.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 9.8% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (53.67) - (4.96) | (8.77) |
| Upside | -18801.6% - -1828.2% | -3154.6% |